Ashish H Shah1, Shakeel A Qureshi2,3,4, Richard A Krasuski3. 1. Section of Cardiology, University of Manitoba, Winnipeg, MB, R2H 2A6, Canada. ashah5@sbgh.mb.ca. 2. Section of Cardiology, University of Manitoba, Winnipeg, MB, R2H 2A6, Canada. 3. Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK. 4. Division of Cardiology, Duke University Health System, Durham, NC, USA.
Abstract
PURPOSE OF REVIEW: Establishing the Fontan circulation has led to improved survival in patients born with complex congenital heart diseases. Despite early success, the long-term course of Fontan patients is complicated by multi-organ dysfunction, mainly due to a combination of low resting and blunted exercise-augmented cardiac output as well as elevated central venous (Fontan) pressure. Similarly, despite absolute hemodynamic differences compared to the normal population with biventricular circulation, the "normal" ranges of hemodynamic parameters specific to age-appropriate Fontan circulation have not been well defined. With the ever-increasing population of patients requiring Fontan correction, it is of utmost importance that an acceptable range of hemodynamics in this highly complex patient cohort is better defined. RECENT FINDINGS: Multiple publications have described hemodynamic limitations and potential management options in patients with Fontan circulation; however, an acceptable range of hemodynamic parameters in this patient population has not been well defined. Identification of "normal" hemodynamic parameters among patients with Fontan circulation will allow physicians to more objectively define indications for intervention, which is a necessary first step to eliminate institutional and regional heterogeneity in Fontan management and potentially improve long-term clinical outcomes.
PURPOSE OF REVIEW: Establishing the Fontan circulation has led to improved survival in patients born with complex congenital heart diseases. Despite early success, the long-term course of Fontan patients is complicated by multi-organ dysfunction, mainly due to a combination of low resting and blunted exercise-augmented cardiac output as well as elevated central venous (Fontan) pressure. Similarly, despite absolute hemodynamic differences compared to the normal population with biventricular circulation, the "normal" ranges of hemodynamic parameters specific to age-appropriate Fontan circulation have not been well defined. With the ever-increasing population of patients requiring Fontan correction, it is of utmost importance that an acceptable range of hemodynamics in this highly complex patient cohort is better defined. RECENT FINDINGS: Multiple publications have described hemodynamic limitations and potential management options in patients with Fontan circulation; however, an acceptable range of hemodynamic parameters in this patient population has not been well defined. Identification of "normal" hemodynamic parameters among patients with Fontan circulation will allow physicians to more objectively define indications for intervention, which is a necessary first step to eliminate institutional and regional heterogeneity in Fontan management and potentially improve long-term clinical outcomes.
Authors: William R Miranda; Barry A Borlaug; Donald J Hagler; Heidi M Connolly; Alexander C Egbe Journal: Eur J Heart Fail Date: 2019-01-23 Impact factor: 15.534
Authors: Brooke T Davey; Olga H Toro-Salazar; Naomi Gauthier; Anne Marie Valente; Robert W Elder; Fred M Wu; Norman Berman; Phyllis Pollack; Ji Hyun Lee; Rahul H Rathod Journal: Congenit Heart Dis Date: 2019-10-23 Impact factor: 2.007
Authors: Paul Khairy; Susan M Fernandes; John E Mayer; John K Triedman; Edward P Walsh; James E Lock; Michael J Landzberg Journal: Circulation Date: 2007-12-10 Impact factor: 29.690
Authors: Makoto Mori; Camden Hebson; Kayoko Shioda; Robert W Elder; Brian E Kogon; Fred H Rodriguez; Maan Jokhadar; Wendy M Book Journal: Congenit Heart Dis Date: 2016-03-02 Impact factor: 2.007
Authors: Emmanuel Akintoye; William R Miranda; Gruschen R Veldtman; Heidi M Connolly; Alexander C Egbe Journal: Heart Date: 2018-10-30 Impact factor: 5.994
Authors: Devaraj Navaratnam; Samantha Fitzsimmons; Michael Grocott; Harry B Rossiter; Yaso Emmanuel; Gerard-Paul Diller; Timothy Gordon-Walker; Sandy Jack; Nick Sheron; John Pappachan; Jayant Nick Pratap; Joseph J Vettukattil; Gruschen Veldtman Journal: Am J Cardiol Date: 2016-03-03 Impact factor: 2.778